Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Short Bowel Syndrome

• Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome
• Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
• A Phase 1 Study of NST-6179 in Healthy Subjects
• A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Who Are 4 Months or Older
• Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
• The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome
• VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.
• Metabolic Balance Study of Apraglutide in Patients With SBS-IF and Colon-in-Continuity
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
• Phase 2 Study to Assess the Safety, PK, and PD in SBS-IF Subjects
• Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
• Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
• Proof of Concept Study in Patients With Short Bowel Syndrome
• Pharmacokinetics of Apixaban in Patients With Short Bowel Syndrome Requiring Long Term Parenteral Nutrition
• A Study of the Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
• Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
• Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
• Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
• An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004
• Use of Tocofersolan (Vedrop®) to Prevent or Treat Refractive Vitamin E Deficiency in Infants and Children
• Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
• Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
• Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support
• Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency
• Liraglutide on Decreasing Parenteral Support in Short Bowel Patients (SLIPS)
• A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302
• Use of Pancreatic Enzymes in Short Bowel Syndrome
• SMOFLipid in Patients Who Are Intralipid Intolerant
• Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral Support
• Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)
• Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 Study
• Safety and Efficacy Study in Infant With SBS
• A Phase 2 Trial Testing ZP1848 in Patients With SBS
• Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
• The Use of DPP-4 Inhibitors in Short Bowel Syndrome
• Compassionate Use of Omegaven in Children
• rtPA in in the Prevention of CVAD-Associated Thrombosis and Infection in Pediatric Patients With Short Bowel Syndrome
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)
• Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
• A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001
• A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
• Short Bowel Syndrome and Teduglutide Versus Placebo
• The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients
• A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
• Safer Parenteral Nutrition in Pediatric Short Bowel Syndrome to Decrease Liver Damage
• Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
• Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver Disease
• Prescription Pattern of Adjuvant Drugs and Vitamins in Patients Undergoing Long-term Home Nutritional Support for Intestinal Insufficiency
• Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
• Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure
• A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021
• Evaluation of the Clinical Practice of Using of a 70% Ethanol Lock Solution for the Prevention of Catheter Related Blood Stream Infections in Pediatric Patients Undergoing Intestinal Rehabilitation
• rHGH and Intestinal Permeability in Intestinal Failure
• Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
• Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
• Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease
• Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)
• Cholestasis Reversal: Efficacy of IV Fish Oil
• Pharmacokinetics of Citalopram in Patients With Short Bowel Syndrome
• Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects
• Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
• Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)
• Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
• Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
• Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
• Diet/Growth Factor Mechanisms of Gut Adaptation